» Articles » PMID: 37812721

Direct Neuronal Conversion of Microglia/macrophages Reinstates Neurological Function After Stroke

Overview
Specialty Science
Date 2023 Oct 9
PMID 37812721
Authors
Affiliations
Soon will be listed here.
Abstract

Although generating new neurons in the ischemic injured brain would be an ideal approach to replenish the lost neurons for repairing the damage, the adult mammalian brain retains only limited neurogenic capability. Here, we show that direct conversion of microglia/macrophages into neurons in the brain has great potential as a therapeutic strategy for ischemic brain injury. After transient middle cerebral artery occlusion in adult mice, microglia/macrophages converge at the lesion core of the striatum, where neuronal loss is prominent. Targeted expression of a neurogenic transcription factor, NeuroD1, in microglia/macrophages in the injured striatum enables their conversion into induced neuronal cells that functionally integrate into the existing neuronal circuits. Furthermore, NeuroD1-mediated induced neuronal cell generation significantly improves neurological function in the mouse stroke model, and ablation of these cells abolishes the gained functional recovery. Our findings thus demonstrate that neuronal conversion contributes directly to functional recovery after stroke.

Citing Articles

In vivo direct neuronal conversion as a therapeutic strategy for ischemic stroke.

Irie T, Matsuda T Neural Regen Res. 2024; 20(8):2309-2310.

PMID: 39359083 PMC: 11759033. DOI: 10.4103/NRR.NRR-D-24-00545.


Changes in Neuroimmunological Synapses During Cerebral Ischemia.

Bitar L, Puig B, Oertner T, Denes A, Magnus T Transl Stroke Res. 2024; .

PMID: 39103660 DOI: 10.1007/s12975-024-01286-1.


Glia-to-neuron reprogramming to the rescue?.

Hickmott J, Morshead C Neural Regen Res. 2024; 20(5):1395-1396.

PMID: 39075900 PMC: 11624859. DOI: 10.4103/NRR.NRR-D-24-00281.


Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome.

Mseis-Jackson N, Sharma M, Li H Cells. 2024; 13(14.

PMID: 39056804 PMC: 11274869. DOI: 10.3390/cells13141223.


In vivo neural regeneration via AAV-NeuroD1 gene delivery to astrocytes in neonatal hypoxic-ischemic brain injury.

Kim M, Oh S, Kim S, Kim I, Kim J, Han J Inflamm Regen. 2024; 44(1):33.

PMID: 39014391 PMC: 11253351. DOI: 10.1186/s41232-024-00349-y.


References
1.
Balkaya M, Krober J, Gertz K, Peruzzaro S, Endres M . Characterization of long-term functional outcome in a murine model of mild brain ischemia. J Neurosci Methods. 2013; 213(2):179-87. DOI: 10.1016/j.jneumeth.2012.12.021. View

2.
Gulyas B, Toth M, Schain M, Airaksinen A, Vas A, Kostulas K . Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine. J Neurol Sci. 2012; 320(1-2):110-7. DOI: 10.1016/j.jns.2012.06.026. View

3.
Greenhalgh A, David S, Bennett F . Immune cell regulation of glia during CNS injury and disease. Nat Rev Neurosci. 2020; 21(3):139-152. DOI: 10.1038/s41583-020-0263-9. View

4.
Torper O, Ottosson D, Pereira M, Lau S, Cardoso T, Grealish S . In Vivo Reprogramming of Striatal NG2 Glia into Functional Neurons that Integrate into Local Host Circuitry. Cell Rep. 2015; 12(3):474-81. PMC: 4521079. DOI: 10.1016/j.celrep.2015.06.040. View

5.
Matsuda T, Irie T, Katsurabayashi S, Hayashi Y, Nagai T, Hamazaki N . Pioneer Factor NeuroD1 Rearranges Transcriptional and Epigenetic Profiles to Execute Microglia-Neuron Conversion. Neuron. 2019; 101(3):472-485.e7. DOI: 10.1016/j.neuron.2018.12.010. View